Drug profile · INN
trelagliptin succinate
ZAFATEK
trelagliptin succinate (ZAFATEK) is a dipeptidyl peptidase iv inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — trelagliptin succinate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
trelagliptin succinate (ZAFATEK) is a dipeptidyl peptidase iv inhibitor.
Key facts
INN trelagliptin succinate
Brand ZAFATEK
Mechanism Dipeptidyl peptidase IV inhibitor
Target Dipeptidyl peptidase 4
Mechanism of action
Dipeptidyl peptidase IV inhibitor
Primary target: Dipeptidyl peptidase 4
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is trelagliptin succinate?
trelagliptin succinate (ZAFATEK) is a dipeptidyl peptidase iv inhibitor.
What is the brand name for trelagliptin succinate?
ZAFATEK is a marketed brand name for trelagliptin succinate. Check FDA Drugs@FDA for the current US label holder and prescribing information.